These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17546056)

  • 1. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.
    Kitisin K; Ganesan N; Tang Y; Jogunoori W; Volpe EA; Kim SS; Katuri V; Kallakury B; Pishvaian M; Albanese C; Mendelson J; Zasloff M; Rashid A; Fishbein T; Evans SR; Sidawy A; Reddy EP; Mishra B; Johnson LB; Shetty K; Mishra L
    Oncogene; 2007 Nov; 26(50):7103-10. PubMed ID: 17546056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.
    Baek HJ; Lim SC; Kitisin K; Jogunoori W; Tang Y; Marshall MB; Mishra B; Kim TH; Cho KH; Kim SS; Mishra L
    Hepatology; 2008 Oct; 48(4):1128-37. PubMed ID: 18704924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
    Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
    Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice.
    Tang Y; Katuri V; Dillner A; Mishra B; Deng CX; Mishra L
    Science; 2003 Jan; 299(5606):574-7. PubMed ID: 12543979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle deregulation and loss of stem cell phenotype in the subventricular zone of TGF-beta adaptor elf-/- mouse brain.
    Golestaneh N; Tang Y; Katuri V; Jogunoori W; Mishra L; Mishra B
    Brain Res; 2006 Sep; 1108(1):45-53. PubMed ID: 16884701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer.
    Baek HJ; Pishvaian MJ; Tang Y; Kim TH; Yang S; Zouhairi ME; Mendelson J; Shetty K; Kallakury B; Berry DL; Shin KH; Mishra B; Reddy EP; Kim SS; Mishra L
    Hepatology; 2011 May; 53(5):1676-84. PubMed ID: 21520178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of TGF-beta signaling in lung cancer results in increased CDK4 activity that can be rescued by ELF.
    Baek HJ; Kim SS; da Silva FM; Volpe EA; Evans S; Mishra B; Mishra L; Marshall MB
    Biochem Biophys Res Commun; 2006 Aug; 346(4):1150-7. PubMed ID: 16782056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis.
    Wang Z; Liu F; Tu W; Chang Y; Yao J; Wu W; Jiang X; He X; Lin J; Song Y
    J Cell Mol Med; 2012 Jan; 16(1):118-28. PubMed ID: 21388516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF.
    Kim SS; Shetty K; Katuri V; Kitisin K; Baek HJ; Tang Y; Marshall B; Johnson L; Mishra B; Mishra L
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1216-23. PubMed ID: 16650383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical interactions between TGF-beta signaling/ELF, and E-cadherin/beta-catenin mediated tumor suppression.
    Katuri V; Tang Y; Li C; Jogunoori W; Deng CX; Rashid A; Sidawy AN; Evans S; Reddy EP; Mishra B; Mishra L
    Oncogene; 2006 Mar; 25(13):1871-86. PubMed ID: 16288220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
    Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis.
    Tang Y; Katuri V; Srinivasan R; Fogt F; Redman R; Anand G; Said A; Fishbein T; Zasloff M; Reddy EP; Mishra B; Mishra L
    Cancer Res; 2005 May; 65(10):4228-37. PubMed ID: 15899814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133 induced tumorigenicity mice express TGF-beta receptor type II (TBRII) and embryonic liver fodrin (ELF) along with stem cell markers.
    Dong YM; Jiao SC
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2296-301. PubMed ID: 27338054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RING finger-dependent ubiquitination by PRAJA is dependent on TGF-beta and potentially defines the functional status of the tumor suppressor ELF.
    Saha T; Vardhini D; Tang Y; Katuri V; Jogunoori W; Volpe EA; Haines D; Sidawy A; Zhou X; Gallicano I; Schlegel R; Mishra B; Mishra L
    Oncogene; 2006 Feb; 25(5):693-705. PubMed ID: 16247473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
    Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
    Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells.
    Sandhu C; Garbe J; Bhattacharya N; Daksis J; Pan CH; Yaswen P; Koh J; Slingerland JM; Stampfer MR
    Mol Cell Biol; 1997 May; 17(5):2458-67. PubMed ID: 9111314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.